Clinical Trial Update: Melanole, a Dietary Supplement, for the Treatment of Gastroesophageal Reflux Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for Melanole, a dietary supplement, evaluating its use for gastroesophageal reflux disease across Phase 2 and Phase 3, with the current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Melanole

Snippet

Sponsor: Lebanese American University | Conditions: GERD | Phase 2, Phase 3 | Status: UNKNOWN